严重创伤院前复苏策略对死亡率疗效比较:网状Meta分析
该网状Meta分析纳入15项RCT共7504例严重创伤患者,比较院前血液复苏(红细胞+血浆、红细胞、血浆)与非血液复苏(静脉晶体液+右旋糖酐、仅静脉晶体液、氨甲环酸)对24小时和28天死亡率的影响。以仅静脉晶体液为对照,各策略在24小时和28天死亡率上均无显著差异(所有OR的95%CI均跨1)。基于排序概率,红细胞+血浆在24小时死亡率排名最高(65.8%),氨甲环酸在28天死亡率排名最高(74.6%)。作者结论为当前证据不足以支持任一院前干预的优越性,需未来大规模RCT明确院前血液与非血液复苏策略的作用。
要点
- 15项RCT共7504例严重创伤患者,院前血液与非血液复苏策略对24小时和28天死亡率均无显著差异。
- 与仅静脉晶体液相比,红细胞+血浆24小时死亡率OR 0.68(95%CI 0.38-1.22),未达统计学显著。
- 与仅静脉晶体液相比,氨甲环酸24小时死亡率OR 0.73(95%CI 0.52-1.04),未达统计学显著。
- 排序概率:红细胞+血浆24小时死亡率排名最高(65.8%),氨甲环酸28天死亡率排名最高(74.6%)。
- 作者认为当前证据不足以支持任一院前复苏策略的优越性,需未来大规模RCT进一步明确。
适用人群与场景
- 严重创伤患者(纳入标准为原始RCT中定义的严重创伤人群)。
研究设计与关键结果
- 研究类型:网状Meta分析,纳入15项随机对照试验,共7504例严重创伤患者;检索PubMed、CINAHL、Cochrane Library、Web of Science及相关参考文献。
- 干预与对照:院前血液复苏(红细胞+血浆、红细胞、血浆)与非血液复苏(静脉晶体液+右旋糖酐、仅静脉晶体液、氨甲环酸);主要终点为24小时和28天死亡率,效应量为OR及95%CI。
- 24小时死亡率(对照为仅静脉晶体液):红细胞+血浆OR 0.68(95%CI 0.38-1.22)、血浆OR 0.72(95%CI 0.46-1.16)、氨甲环酸OR 0.73(95%CI 0.52-1.04)、红细胞OR 0.81(95%CI 0.22-3.08)、静脉晶体液+右旋糖酐OR 0.91(95%CI 0.65-1.28),均无显著差异。
- 28天死亡率(对照为仅静脉晶体液):氨甲环酸OR 0.83(95%CI 0.35-1.92)、静脉晶体液+右旋糖酐OR 0.84(95%CI 0.46-1.52)、红细胞+血浆OR 0.88(95%CI 0.21-3.73)、红细胞OR 0.94(95%CI 0.10-8.64)、血浆OR 0.97(95%CI 0.38-2.46),均无显著差异。
- 排序概率:24小时死亡率红细胞+血浆排名最高(65.8%);28天死亡率氨甲环酸排名最高(74.6%)。
证据类型、等级与局限
- 证据类型:随机对照试验的网状Meta分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:院前血液(红细胞+血浆、红细胞、血浆)与非血液(静脉晶体液+右旋糖酐、氨甲环酸)复苏策略对早期和晚期死亡率的影响相当且无显著差异。
- 作者认为当前证据不足以支持单一院前干预的优越性,未来需大规模RCT明确院前血液与非血液复苏策略的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND AND IMPORTANCE: Patients with major trauma face high rates of coagulopathy, hemorrhage, and organ failure, with prehospital resuscitation strategies critical for stabilization. Comparative evidence on prehospital blood [red blood cells (RBCs) and plasma] and non-blood [intravenous crystalloids and dextran, intravenous crystalloids only, and tranexamic acid (TXA)] resuscitation strategies remains limited and inconclusive.
OBJECTIVES: To evaluate and compare the efficacy of prehospital blood and non-blood resuscitation strategies in patients with major trauma using network meta-analysis.
DESIGN, SETTINGS, AND PARTICIPANTS: Network meta-analysis of randomized controlled trials (RCTs). Databases: PubMed, CINAHL, Cochrane Library, and Web of Science and reference lists of relevant previous studies. Participants: patients with major trauma.
INTERVENTION OR EXPOSURE: Prehospital blood (RBC + plasma, RBC, and plasma) and non-blood (intravenous crystalloids + dextran, intravenous crystalloids only, and TXA) resuscitation strategies.
OUTCOME MEASURE AND ANALYSIS: Study outcomes were 24-h and 28-day mortality. Data analysis was performed using Frequentist and Bayesian frameworks on MetaInsight, an R-Language web-based analytical platform, presenting odds ratio (OR) and corresponding 95% confidence interval (95% CI). Ranking of prehospital resuscitation strategies was confirmed by the surface under cumulative ranking.
MAIN RESULTS: A total of 15 RCTs involving 7504 participants were included. Compared with intravenous crystalloids only, RBC + plasma (OR: 0.68, 95% CI: 0.38-1.22), plasma (OR: 0.72, 95% CI: 0.46-1.16), TXA (OR: 0.73, 95% CI: 0.52-1.04), RBC (OR: 0.81, 95% CI: 0.22-3.08), and intravenous crystalloids + dextran (OR: 0.91, 95% CI: 0.65-1.28) demonstrated no significant difference in reducing 24-h mortality. Similarly, TXA (OR: 0.83, 95% CI: 0.35-1.92), intravenous crystalloids + dextran (OR: 0.84, 95% CI: 0.46-1.52), RBC + plasma (OR: 0.88, 95% CI: 0.21-3.73), RBC (OR: 0.94, 95% CI: 0.10-8.64), and plasma (OR: 0.97, 95% CI: 0.38-2.46) revealed no significant difference in reducing 28-day mortality compared with intravenous crystalloids only. Based on ranking probabilities, RBC + plasma (65.8%) for 24-h mortality and TXA (74.6%) for 28-day mortality were ranked highest.
CONCLUSION: Prehospital blood (RBC + plasma, RBC, and plasma) and non-blood (intravenous crystalloids + dextran and TXA) resuscitation strategies were associated with comparable nonsignificant effects on early and late mortality. Current evidence is insufficient to support the superiority of a single prehospital intervention with future large-scale RCTs needed to clarify role of prehospital blood and non-blood resuscitation strategies.
参考来源
- Hsu CW, Hung WK, Chilinda ZB, et al. Comparative efficacy of prehospital resuscitation strategies on mortality for patients with major trauma: a network meta-analysis. Eur J Emerg Med. 2026. PMID: 41661170. doi:10.1097/MEJ.0000000000001315
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。